XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021   30,181,348      
Beginning balance at Dec. 31, 2021 $ 1,034,519 $ 30 $ 606,392 $ 428,260 $ (163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,737     3,737  
Unrealized gain (loss) on investment, net of taxes (181)       (181)
Stock-based compensation 1,532   1,552 (20)  
Issuance of restricted and deferred stock units (in shares)   37,879      
Issuance of restricted and deferred stock units (1,269)   (1,269)    
Employee stock purchase plan (in shares)   17,918      
Employee stock purchase plan 1,049   1,049    
Common stock issuance, net of costs (87)   (87)    
Dividends paid (10,882)     (10,882)  
Ending balance (in shares) at Mar. 31, 2022   30,237,145      
Ending balance at Mar. 31, 2022 $ 1,028,418 $ 30 607,637 421,095 (344)
Beginning balance (in shares) at Dec. 31, 2022 30,801,912 30,801,912      
Beginning balance at Dec. 31, 2022 $ 1,110,868 $ 31 651,004 458,356 1,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 11,530     11,530  
Unrealized gain (loss) on investment, net of taxes 93       93
Stock-based compensation 1,177   1,199 (22)  
Issuance of restricted and deferred stock units (in shares)   38,776      
Issuance of restricted and deferred stock units (1,538)   (1,538)    
Employee stock purchase plan (in shares)   16,410      
Employee stock purchase plan 1,080   1,080    
Common stock issuance, net of costs (in shares)   570,026      
Common stock issuance, net of costs 40,997   40,997    
Dividends paid $ (11,722)     (11,722)  
Ending balance (in shares) at Mar. 31, 2023 31,427,124 31,427,124      
Ending balance at Mar. 31, 2023 $ 1,152,485 $ 31 $ 692,742 $ 458,142 $ 1,570